中文  |  EN
Cells
Mesenchymal Stem Cells(MSC)
Mesenchymal Stem Cells(MSC)

Nuwacell® hiPSC-MSC(RC01005), originally developed by Nuwacell Biotechnologies Co., Ltd. can proliferate stably, have normal karyotypes, express specific cell surface factors (CD73+ / CD90+ / CD105+, CD14-/ CD34- / CD45- / CD79α- / HLA-DR-), and maintain the three-germ line lineages differentiation potential. Nuwacell® hiPSC-MSC can be applied in various in vitro experiments, drug screening and safety evaluation, as well as cell transplantation in disease animal model.

Advantage
  • ✔ Low generation, strong proliferation;
  • ✔ Cell recovery efficiency≥90%;
  • ✔ Cell differentiation potential.
Contents Amount Cat. No. Storage

Nuwacell® hiPSC-MSC(P2)

1×10⁶ RC01005 Liquid nitrogen
Cell morphology

 

The morphorlogy of Nuwacell® hiPSC-MSC cultured at day 3 after passagin. Scale bar, 200 μm.

Cell surface markers

 

Representative flow cytometry analysis of cell surface markers (CD73+ / CD90+ / CD105+, CD14- / CD34- / CD45- / CD79α- / HLA-DR-), in Nuwacell® hiPSC-MSC at passage 5.

Gray line: isotype control; Black line: antigen staining.

 

Differentiation potentia

 

Differentiation potential of Nuwacell® hiPSC-MSC (P5) in ncMission hMSC Medium.

(A) Adipogenic differentiation (oil red staining), (B) Osteogenic differentiation (alizarin red staining), and (C) Cartilage differentiation (alixin blue staining). Scale bar, 200 μm.

Karyotype

 

Karyotype analysis of primary Nuwacell® hiPSC-MSC (P5) was performed on G-banded metaphase chromosomes.

The result shows a normal 46, XX. At least 5 metaphases were examined with approximate resolution of 400 bands per haploid genome.

 

Copyright © 2016-2022 Nuwacell Biotechnologies Co., Ltd. All rights reserved. ICP:16011195
Public security record No 34019202001635 Clause